Par Pharmaceutical: End Payors Latest To Drop Bankruptcy-Blocked Par Claims

Health benefit funds and other end payors became the latest plaintiffs Wednesday to drop Par Pharmaceuticals, now in the middle of bankruptcy, from consolidated litigation accusing the drugmaker and Novartis of hatching an illegal deal to delay generic versions of the blood pressure drug Exforge.